Post-translational modifications in anaplastic thyroid carcinoma: biological mechanisms and therapeutic potential. [PDF]
Zhong L +5 more
europepmc +1 more source
Objectives Evaluate the efficacy and safety of baricitinib in paediatric patients with active JIA‐U or chronic anterior ANA‐positive uveitis, who had an inadequate response to MTX or bDMARDs. Methods JUVE‐BRIGHT was an open‐label, active‐controlled, Phase‐3 multicentre trial which utilized a novel design, including 1:1 randomization to an active ...
Athimalaipet V. Ramanan +7 more
wiley +1 more source
Relationship between creatine kinase and gastric cancer: A two-sample Mendelian randomization study. [PDF]
Tu Y, Xie D, Qian H.
europepmc +1 more source
Objective We aimed to compare clinical outcomes between patients in the Allegheny Health Network rheumatoid arthritis (RA) care pathway and patients receiving usual care. Methods The care pathway initiative implements guideline‐based best practice alongside multi‐disciplinary team‐based care. Clinical and insurance claims data were extracted to compare
Tarun Sharma +7 more
wiley +1 more source
Focal adhesion kinase: A promising regulator of colitis-associated healing. [PDF]
Malek KK +4 more
europepmc +1 more source
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against NSAID use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal trends in prescription NSAID and ...
Adam S. Mayer +5 more
wiley +1 more source
Leveraging artificial intelligence and machine learning in kinase inhibitor development: advances, challenges, and future prospects. [PDF]
Elgawish MS +3 more
europepmc +1 more source
Deciphering the unique autoregulatory mechanisms and substrate specificity of the understudied DCLK3 kinase linked to neurodegenerative diseases. [PDF]
Lu JD +8 more
europepmc +1 more source
Comparative Molecular Dynamics Reveals How LRRK2 Inhibitors Distinguish G2019S from Wild-Type. [PDF]
Wei C, Heh CH, Lit LC, Chin SP.
europepmc +1 more source
Targeted design, synthesis, molecular dynamics, ADME and in -vitro anticancer assessment of oxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids as potential BRAF<sup>V600E</sup> inhibitors. [PDF]
Singh AK +9 more
europepmc +1 more source

